Quick Answer
P3 Health Partners Inc. reported Total Revenue of $1.46 billion for fiscal year 2025.
P3 Health Partners Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.46B -2.8% |
$1.50B +18.5% |
$1.27B +20.7% |
$1.05B +81.4% |
$578.60M +17.8% |
$491.06M +237.5% |
| Revenue (ASC 606) | $1.46B -2.8% |
$1.50B +18.5% |
$1.27B +20.7% |
$1.05B +81.4% |
$578.60M +17.8% |
$491.06M +237.5% |
| Net Income | -$147.95M -8.9% |
-$135.85M -135.1% |
-$57.77M +78.6% |
-$270.13M -84.5% |
-$146.40M -366.1% |
-$31.41M +25.2% |
| Diluted EPS | -$45.26 +16.3% |
-$54.06 -8481.0% |
-$0.63 +90.3% |
-$6.50 -2608.3% |
-$0.24 | — |
| Total Assets | $656.64M -16.2% |
$783.42M -9.0% |
$860.97M -1.8% |
$876.57M -62.9% |
$2.36B +2121.2% |
$106.44M |
| Cash and Equivalents | $25.01M -35.6% |
$38.82M +6.9% |
$36.32M +107.1% |
$17.54M +230.8% |
$5.30M -85.4% |
$36.26M +11.3% |
| Long-Term Debt | $228.37M +109.7% |
$108.91M +0.5% |
$108.32M +14.7% |
$94.42M +18.0% |
$80.00M +76.3% |
$45.39M |
| Stockholders Equity | -$155.23M -304.4% |
$75.94M -46.6% |
$142.13M +2327.9% |
$5.85M -97.9% |
$283.63M | — |
| Operating Income | -$270.30M +15.7% |
-$320.66M -90.9% |
-$167.93M +89.2% |
-$1.56B -1109.5% |
-$129.06M -351.4% |
-$28.59M +27.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $345.25M | -4.7% | -3.0% |
| Revenue (ASC 606) | September 30, 2025 | $345.25M | -4.7% | -3.0% |
| Net Income | September 30, 2025 | -$31.59M | +32.1% | -55.1% |
| Diluted EPS | September 30, 2025 | -$9.67 | +38.4% | -55.2% |
| Total Assets | September 30, 2025 | $683.56M | -18.0% | -6.6% |
| Cash and Equivalents | September 30, 2025 | $37.71M | -40.1% | -2.2% |
| Long-Term Debt | September 30, 2025 | $214.18M | +60.8% | +110.1% |
| Stockholders Equity | September 30, 2025 | -$18.69M | -115.5% | -142.0% |
| Operating Income | September 30, 2025 | -$44.22M | +58.7% | -29.6% |
- P3 Health Partners Inc. reported Total Revenue of $1.46 billion for fiscal year 2025.
- P3 Health Partners Inc. showed a decrease of -2.8% in Total Revenue compared to the prior fiscal year.
- P3 Health Partners Inc. reported Revenue (ASC 606) of $1.46 billion for fiscal year 2025.
- P3 Health Partners Inc. showed a decrease of -2.8% in Revenue (ASC 606) compared to the prior fiscal year.
- P3 Health Partners Inc. reported Net Income of -$147.95 million for fiscal year 2025.
- P3 Health Partners Inc. showed a decrease of -8.9% in Net Income compared to the prior fiscal year.
- P3 Health Partners Inc. reported Diluted EPS of $45.26 per share (loss) for fiscal year 2025.
- P3 Health Partners Inc. showed an increase of +16.3% in Diluted EPS compared to the prior fiscal year.
- P3 Health Partners Inc. reported Total Assets of $656.64 million for fiscal year 2025.
- P3 Health Partners Inc. showed a decrease of -16.2% in Total Assets compared to the prior fiscal year.
- P3 Health Partners Inc. reported Cash and Equivalents of $25.01 million for fiscal year 2025.
- P3 Health Partners Inc. showed a decrease of -35.6% in Cash and Equivalents compared to the prior fiscal year.
- P3 Health Partners Inc. reported Long-Term Debt of $228.37 million for fiscal year 2025.
- P3 Health Partners Inc. showed an increase of +109.7% in Long-Term Debt compared to the prior fiscal year.
- P3 Health Partners Inc. reported Stockholders Equity of -$155.23 million for fiscal year 2025.
- P3 Health Partners Inc. showed a decrease of -304.4% in Stockholders Equity compared to the prior fiscal year.
- P3 Health Partners Inc. reported Operating Income of -$270.30 million for fiscal year 2025.
- P3 Health Partners Inc. showed an increase of +15.7% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: